Tekeli Taşkömür A, Erten Özlem, Dilbaz B. Comparison of two drospirenone-containing oral contraceptives for their effect on the ovary, menstrual cycle, acne, and side-effect profile: 20 µg ethinylestradiol/3 mg drospirenone (24/4) versus 30 µg ethinylestradiol/3 mg drospirenone (21/7). J Surg Med [Internet]. 2021 Nov. 1 [cited 2024 Apr. 25];5(11):1099-103. Available from: https://jsurgmed.com/article/view/1002126